Loading…
Wednesday, June 26 • 4:15pm - 5:30pm
#384: Patient Preferences in Decision Making and the PREFER Project: Past, Present, and Future

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-19-703-L04-P; CME 1.25; IACET 1.25; RN 1.25

Speakers will present an historical overview of decision making, including PREFER’s place in that evolving landscape; the results from the ongoing PREFER project; and how patients and their representatives provide valuable insight into the project.

Learning Objectives

Discuss the evolution of decision making and the expanding role of patient preferences; Describe the aims and results of the PREFER project regarding when and how to integrate patient preferences into medical product decision making from diverse perspectives: industry, regulator, and patient; Identify the value gained by including patient representatives in study development.

Chair

Kristin E Bullok, PhD

Speaker

Benefit-Risk Evaluation with the Patient’s Perspective: Past, Present, and Future
Juhaeri Juhaeri, PhD

Patient Preference Studies: Why, When, and How
Rachael L. DiSantostefano

Patient Involvement in Preference Study Design: A Case Study
Jenny Sharpe, PhD



Speakers
avatar for Kristin Bullok

Kristin Bullok

Benefit-Risk Management Scientist, Global Patient Safety, Eli Lilly and Company
Kristin Bullok, PhD, is a research scientist in benefit-risk management at Eli Lilly and Company, Global Patient Safety. Since joining Lilly, she has years of combined experience in conducting structured benefit-risk assessments, consulting on patient preference trade-off studies... Read More →
avatar for Rachael DiSantostefano

Rachael DiSantostefano

Senior Director, Benefit Risk, Epidemiology, Janssen Research & Development, LLC
Rachael L. DiSantostefano, MS PhD, is a Senior Director of Benefit-Risk in the Epidemiology Department within Janssen Pharmaceuticals, R&D, LLC. She has 25 years of pharmaceutical research experience across the quantitative disciplines of epidemiology, biostatistics, and health outcomes... Read More →
avatar for Juhaeri Juhaeri

Juhaeri Juhaeri

Vice President and Head, Epidemiology and Benefit-Risk Evaluation, Sanofi
Juhaeri Juhaeri, Ph.D., is Vice President and Head of Epidemiology and Benefit-Risk at Sanofi. Juhaeri is an Epidemiologist and Statistician with over 20 year experience in epidemiologic research in academia and in pharmaceutical industry. He joined Sanofi in 2001 where he established... Read More →
avatar for Jenny Sharpe

Jenny Sharpe

Research Communications Manager, Muscular Dystrophy UK
Jenny is Research Communications Manager for Muscular Dystrophy UK, a charity bringing together over 60 rare and ultra-rare muscle weakening and wasting conditions. She is primarily responsible for overseeing the charity’s communications about research. This involves translating... Read More →


Wednesday June 26, 2019 4:15pm - 5:30pm
Room 5AB San Diego Convention Center 111 W Harbor Drive, San Diego, CA 92101 USA